SCHEMBL7057607

SCHEMBL7057607

Cc1[nH]c2ccccc2c1-c1cncn1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.53
LMNA P02545 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
HPGDS O60760 1/20 0.44
AHR P35869 1/20 0.43
IDO1 P14902 2/20 0.43
LDLR P01130 1/20 0.41
PCSK9 Q8NBP7 1/20 0.41
CCR6 P51684 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
EIF2AK2 P19525 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6890020 0.75 IMPDH2 (0.43) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL6772734 0.71 CYP11B2 (0.40) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL21065289 0.71 HTR6 (0.68) IMPDH2MEN1KMT2AALDH1A1HSD17B10
SCHEMBL12318032 0.71 IDO1 (0.50) KDM4EALDH1A1HPGDHPGDSIDO1
SCHEMBL7198661 0.70 GSK3B (0.58) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL31060312 0.69 IMPDH2 (1.00) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL972964 0.69 HPGDS (0.73) ALDH1A1CYP1A2HPGDSIDO1LDLR
SCHEMBL6628898 0.69 IMPDH2 (0.55) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL7812203 0.69 IMPDH2 (0.69) IMPDH2LMNAMEN1KMT2AKDM4E
SCHEMBL29908698 0.69 IMPDH2 (0.55) IMPDH2LMNAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002531-A1 Imidazolyl derivatives SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATION SCIENTEFIQUES, S.A.S., A FRANCE CORPORATION 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002531-A1 Imidazolyl derivatives TPI1, BCHE, CYP51A1 IMPDH2 14/4885LMNA 3800/4885MEN1 1084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.